Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.30% dropped 0.73% to $166.88 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.15% falling 1.59% to 4,258.49 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 2.09% to 33,962.04. This was the stock's third consecutive day of losses. Johnson & Johnson closed $6.77 below its 52-week high ($173.65), which the company reached on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.80% fell 1.74% to $381.72, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.77% fell 1.24% to $77.05, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.57% fell 0.50% to $40.15. Trading volume (8.2 M) eclipsed its 50-day average volume of 6.4 M.